Daniele Derudas

Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial

Antonio Palumbo, Sara Bringhen, Anna Marina Liberati et al. · Blood · 2008 · 357 citations · Full text

Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma

Michèle Cavo, Lucia Pantani, Maria Teresa Petrucci et al. · Blood · 2012 · 309 citations · Full text

Myocardial iron overload assessment by T2* magnetic resonance imaging in adult transfusion dependent patients with acquired anemias

Alessandra Tucci, Gildo Matta, Simona Deplano et al. · Haematologica · 2008 · 139 citations · Full text

Transfusion Dependent, Heart Failure, Iron Metabolism +17

Halting pro-survival autophagy by TGFβ inhibition in bone marrow fibroblasts overcomes bortezomib resistance in multiple myeloma patients

Maria Antonia Frassanito, Kim De Veirman, Vanessa Desantis et al. · Leukemia · 2015 · 81 citations

Hematological Malignancy, Cell Autophagy, Immunology +8

Efficacy and tolerability of bendamustine, bortezomib and dexamethasone in patients with relapsed-refractory multiple myeloma: a phase II study

Massimo Offidani, Laura Corvatta, Laura Maracci et al. · Blood Cancer Journal · 2013 · 61 citations · Full text

Hematological Malignancy, Oncology, Health Sciences +14